Safety of Using NaviFUS System in Patients With Drug Resistant Epilepsy

Clinical trial NCT03860298 · COMPLETED

Trial details

NCT number: NCT03860298
Sponsor: NaviFUS Corporation
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Drug Resistant Epilepsy Epilepsy, Drug Resistant Drug Refractory Epilepsy Epilepsy, Drug Refractory Intractable Epilepsy Epilepsy, Intractable Medication Resistant Epilepsy Refractory Epilepsy

Start date: 2019-06-17
Primary completion: 2020-10-14
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.